DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Indo Borax & Chemicals Limited — Outcome of Board Meeting

NSE 3 hrs ago·10 Aug 2026, 8:16 am

Indo Borax & Chemicals

Indo Borax & Chemicals Limited has informed the stock exchange about its financial results for the period ending June 30, 2026. The company has submitted these details to comply with regulatory disclosure norms.

This update is significant for investors as it provides the latest data on the company's financial health, including its profitability and operational performance. Reviewing these figures helps investors assess the company's current standing and future growth potential.

Investors should watch for the specific numbers in the earnings report, particularly the net profit and revenue growth, to gauge the company's operational efficiency and market position.